Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients With Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?

Pharmaceutics - Switzerland
doi 10.3390/pharmaceutics11110566

Related search